Susquehanna International Group’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.4M | Buy |
2,817,200
+39,200
| +1% | +$220K | ﹤0.01% | 2538 |
|
|
2025
Q4 | $19.4M | Buy |
2,778,000
+1,539,200
| +124% | +$12.1M | ﹤0.01% | 2245 |
|
|
2025
Q3 | $9.58M | Buy |
1,238,800
+543,300
| +78% | +$4.24M | ﹤0.01% | 3098 |
|
|
2025
Q2 | $6.06M | Sell |
695,500
-829,200
| -54% | -$6.01M | ﹤0.01% | 3625 |
|
|
2025
Q1 | $12.1M | Buy |
1,524,700
+198,800
| +15% | +$2.01M | ﹤0.01% | 2280 |
|
|
2024
Q4 | $12.1M | Buy |
1,325,900
+464,600
| +54% | +$4.49M | ﹤0.01% | 2429 |
|
|
2024
Q3 | $7.91M | Buy |
861,300
+143,800
| +20% | +$1.19M | ﹤0.01% | 2937 |
|
|
2024
Q2 | $7.02M | Sell |
717,500
-167,800
| -19% | -$2.05M | ﹤0.01% | 2932 |
|
|
2024
Q1 | $13.4M | Sell |
885,300
-1,363,700
| -61% | -$24.7M | ﹤0.01% | 2232 |
|
|
2023
Q4 | $48.5M | Buy |
2,249,000
+318,700
| +17% | +$5.88M | 0.01% | 1059 |
|
|
2023
Q3 | $35.9M | Buy |
1,930,300
+753,700
| +64% | +$17.6M | 0.01% | 1245 |
|
|
2023
Q2 | $29.8M | Buy |
1,176,600
+233,800
| +25% | +$5.88M | 0.01% | 1370 |
|
|
2023
Q1 | $24.4M | Sell |
942,800
-807,300
| -46% | -$21.6M | 0.01% | 1506 |
|
|
2022
Q4 | $41.4M | Buy |
1,750,100
+221,900
| +15% | +$5.98M | 0.01% | 993 |
|
|
2022
Q3 | $38.7M | Sell |
1,528,200
-524,400
| -26% | -$18.4M | 0.01% | 957 |
|
|
2022
Q2 | $68.2M | Sell |
2,052,600
-69,100
| -3% | -$2.94M | 0.02% | 679 |
|
|
2022
Q1 | $153M | Sell |
2,121,700
-652,400
| -24% | -$47M | 0.03% | 489 |
|
|
2021
Q4 | $255M | Sell |
2,774,100
-510,000
| -16% | -$61M | 0.04% | 387 |
|
|
2021
Q3 | $416M | Sell |
3,284,100
-507,400
| -13% | -$73.9M | 0.06% | 289 |
|
|
2021
Q2 | $630M | Buy |
3,791,500
+1,012,500
| +36% | +$164M | 0.09% | 180 |
|
|
2021
Q1 | $505M | Buy |
2,779,000
+223,200
| +9% | +$51.8M | 0.08% | 198 |
|
|
2020
Q4 | $511M | Buy |
2,555,800
+632,900
| +33% | +$129M | 0.08% | 184 |
|
|
2020
Q3 | $422M | Buy |
1,922,900
+1,046,000
| +119% | +$222M | 0.08% | 179 |
|
|
2020
Q2 | $167M | Buy |
876,900
+430,500
| +96% | +$75.4M | 0.04% | 343 |
|
|
2020
Q1 | $69.2M | Buy |
446,400
+175,100
| +65% | +$20.4M | 0.02% | 525 |
|
|
2019
Q4 | $22.7M | Buy |
271,300
+16,000
| +6% | +$1.22M | 0.01% | 1303 |
|
|
2019
Q3 | $17.3M | Buy |
255,300
+2,100
| +0.8% | +$138K | 0.01% | 1453 |
|
|
2019
Q2 | $16.8M | Buy |
253,200
+105,000
| +71% | +$6.12M | 0.01% | 1421 |
|
|
2019
Q1 | $8.24M | Sell |
148,200
-38,800
| -21% | -$2.37M | ﹤0.01% | 1929 |
|
|
2018
Q4 | $9.27M | Sell |
187,000
-32,200
| -15% | -$1.97M | ﹤0.01% | 1676 |
|
|
2018
Q3 | $18.9M | Buy |
219,200
+140,900
| +180% | +$10M | 0.01% | 1365 |
|
|
2018
Q2 | $4.54M | Buy |
78,300
+6,100
| +8% | +$298K | ﹤0.01% | 2829 |
|
|
2018
Q1 | $2.91M | Sell |
72,200
-123,100
| -63% | -$4.65M | ﹤0.01% | 3305 |
|
|
2017
Q4 | $6.81M | Buy |
195,300
+113,600
| +139% | +$3.77M | ﹤0.01% | 2190 |
|
|
2017
Q3 | $2.71M | Sell |
81,700
-14,700
| -15% | -$482K | ﹤0.01% | 3385 |
|
|
2017
Q2 | $3.35M | Buy |
96,400
+4,400
| +5% | +$128K | ﹤0.01% | 2984 |
|
|
2017
Q1 | $2.3M | Buy |
92,000
+37,800
| +70% | +$786K | ﹤0.01% | 3457 |
|
|
2016
Q4 | $894K | Buy |
54,200
+25,400
| +88% | +$431K | ﹤0.01% | 5768 |
|
|
2016
Q3 | $527K | Buy |
28,800
+12,200
| +73% | +$214K | ﹤0.01% | 5968 |
|
|
2016
Q2 | $266K | Buy |
+16,600
| New | +$194K | ﹤0.01% | 7155 |
|
|
2016
Q1 | – | Sell |
-10,400
| Closed | -$187K | – | 9657 |
|
|
2015
Q4 | $187K | Buy |
+10,400
| New | +$192K | ﹤0.01% | 8483 |
|
Other funds holding TDOC
VPM
VCM
VC
Susquehanna International Group's TDOC Position: Q1 2026 in Review
Susquehanna International Group reduced its Teladoc Health (TDOC) stake by 17% in Q1 2026, selling an estimated $987K and leaving 885,526 shares worth $4.83M. The position accounts for ﹤0.01% of the portfolio, ranked #4299.
Susquehanna International Group first reported a position in TDOC in Q3 2016 and has held it in 36 quarters since. The position peaked at $241M in Q1 2021. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.
- Susquehanna International Group held 885,526 shares of Teladoc Health worth $4.83M as of Q1 2026.
- Susquehanna International Group sold 175,942 Teladoc Health shares in Q1 2026, an estimated $987K.
- Teladoc Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4299 holding.
- Susquehanna International Group first reported a position in Teladoc Health in Q3 2016 and has held it in 36 quarters since.
- Susquehanna International Group's Teladoc Health position peaked at $241M in Q1 2021.
- 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.